June 2 – 5  | San Diego Convention Center | San Diego, California

www.mscare.org/2021

  • General Information
  • CMSC Abstracts
  • Whitaker Abstracts

Event Information

Please Join Us at the 2021 CMSC Annual Meeting

The leading research and educational conference for MS healthcare professionals in North America.

June 2- 5

Conference Address

San Diego Convention Center
111 W Harbor Dr
San Diego, CA 92101
(619) 525-5000

CMSC Abstracts

For questions regarding content, rules, and guidelines, please contact Jennifer Pichardo at [email protected] or at (201) 487-1050 x 115.

For technical support, contact [email protected]. Emails are monitored seven days a week from 7:00am-11:00pm Eastern Time or you can call +1 401.334.0220 Mon-Fri from 8:00am-6:00pm Eastern Time.

Opening Date: October 1, 2020

Submission Deadline: January 10th, 2021

The Consortium of Multiple Sclerosis Centers (CMSC) invites submissions for Poster and/or Platform presentations that address timely issues involving MS basic and clinical research, patient care and treatment outcomes. Submissions that reflect collaboration between specialties are encouraged.
The categories to be highlighted include:

  • Diagnosis and Prognosis
  • Basic Science
  • Mental Health and Psychosocial Issues
  • Comprehensive Clinical Care – The Team Approach
  • Disease Modification and its Outcomes
  • Epidemiology, Genetics, and Epigenetics
  • Neuroimaging and Neurophysiology
  • Programs that Support Quality of Life
  • Rehabilitation Research and Strategies
  • Symptom Management
  • Advances in Technology
  • Patient Reported Outcomes
  • Programs and Methods of Care
  • Case Reports/Case Series

INSTRUCTIONS AND GUIDELINES

All healthcare professionals are welcome to submit abstracts. Authors need not be members of CMSC or be sponsored by a member. Acceptance will be based entirely upon the quality of the work and the appropriateness of the topic.

Submission of a proposal implies a commitment to present at the meeting. Authors of accepted abstracts must register for the conference. The CMSC cannot assist with your costs. You may apply for scholarship support but this process is separate from the abstract review and approval of your work.

CMSC STATEMENT ON COMMERCIAL INTEREST AUTHORS AND PRESENTERS

Platform Presentations: In support of improving patient care, the Consortium of Multiple Sclerosis Centers (CMSC) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. CMSC is committed to comply with the rules and guidelines set forth by these agencies to ensure that these standards are strictly followed. The work of commercial interest authors and presenters will be considered for review provided that the content focuses on basic science and not on the product or on the commercial aspects of the discovery. Acceptance of an abstract for Platform presentation depends solely on the decision of the CMSC Abstract Review Committee in consultation with the CMSC CE Committee.

Poster Presentations: Authors of poster submissions should present information about studies or projects of benefit to the multiple sclerosis scientific and/or clinical community. The work of authors who are industry employees will be considered provided that the authors are employed by the scientific and/or medical divisions. The work of authors in industry sales or marketing posts will not be considered for inclusion in the scientific poster session. This policy shall apply to work submitted individually or in a co-authoring capacity.

ACCEPTED ABSTRACTS

Review Process: The CMSC Abstract Review Committee will review all abstracts. Submissions will be evaluated for clarity, relevance to MS, originality, scientific merit, and for the purpose of resolution of any identified conflict of interest (COI) on the part of the author(s). Submissions will be evaluated on an equal basis, whether theme-related or of general interest, although preference will be given to data-based submissions for platform presentations.

Notification: Authors will be notified of acceptance or rejection of abstracts no later than February 29, 2021. All communication will be made through the contact person.

Registration: All Platform and Poster presenters must register for the meeting and will be required to cover all costs related to their annual meeting attendance.

Scholarships: The Consortium of Multiple Sclerosis Centers provides scholarships to MS professionals who wish to attend the annual meeting and require financial assistance. All applicants must meet defined criteria to be eligible. Please go to the Scholarship tab to obtain full information.

TYPES OF PRESENTATIONS

Platforms: The presenters of abstracts selected as Platforms must be available to present on Thursday, Thursday, June 3rd, 2021 from 2:45 pm – 4:45 pm. The exact time of each platform presentation will be posted in the proceedings of the program. The presentation should not exceed fifteen (15) minutes with five (5) minutes for questions and answers. Due to limited time, some submissions requesting platform presentations may be assigned to the poster session. Platform sessions will be awarded continuing education credit.

Posters: For abstracts selected as posters, the presenter must be available to hang the poster, and will be responsible for the material and supplies needed to present the poster. The size of the poster is four (4) feet in height and eight (8) feet in width. Posters may be hung beginning on Wednesday, June 2nd at 12:00 pm. There will be a Poster session on Thursday, June 3rd from 4:30 pm – 7:00 pm. Authors will be expected to stand by their work between 5:00 pm – 7:30 pm and be available for discussion during the poster session.

PUBLICATION

All accepted abstracts will be published for distribution during the meeting and posted on the CMSC Annual Meeting website at www.mscare.org/2021.

AWARDS

The CMSC offers a number of awards in recognition of the quality of work submitted. The CMSC Research Award will be given to the best Platform and Poster presentations of innovative research in multiple sclerosis. The Patient and Family Education Award will be given to the best Platform and Poster presentations focusing on patient and family education in MS. The Labe C. Scheinberg Award will be presented by the Foundation of the CMSC to the Platform or Poster presentation that has the greatest impact in advancing the care of people with MS. Reviewers will recommend an abstract to be considered for any of the awards.

Research and Education award winners will receive a plaque and free registration to a subsequent CMSC Annual Meeting for the first author only. The Scheinberg awardee will receive a trophy and a cash award from the Foundation of the CMSC.

Whitaker Research
Track Abstracts

For questions regarding content, rules, and guidelines, please contact Jennifer Pichardo at [email protected] or at (201) 487-1050 x 115.

For technical support, contact [email protected]. Emails are monitored seven days a week from 7:00am-11:00pm Eastern Time or you can call +1 401.334.0220 Mon-Fri from 8:00am-6:00pm Eastern Time.

Opening Date: October 1, 2020
Submission Deadline:
January 10th, 2020

Dr. John N. Whitaker was a world famous researcher in multiple sclerosis. Not only did Dr. Whitaker engage in research himself, he encouraged budding scientists to enter the field and develop their skills and talents in this important work. The CMSC is proud to honor Dr. Whitaker’s memory by presenting the Whitaker Research Track each year as part of its annual meeting. This project of the CMSC includes the work of emerging scientists working in the field of MS. Students, post-doctoral fellows, and young investigators are encouraged to submit abstracts of their work for presentation during the Whitaker Track. A panel, headed by Dr. Michael Racke, will judge the presentations and will award the Whitaker Prize for MS Research. A monetary grant will be awarded by the Foundation of the CMSC to the winner to support his or her continued work in the field of MS. The Whitaker Platform Session will take place on Wednesday, June 2. Investigators whose abstracts are chosen will be provided with transportation, hotel accommodations for two nights and complimentary registration.

INSTRUCTIONS AND GUIDELINES

Submission of a proposal implies a commitment to present at the meeting. Authors of accepted abstracts must register for the conference. Restrictions: No continuation page, illustrations or tables are to be included. Abstracts must report work not presented or published prior to the meeting. Disclosure Statement: This statement must be completed by all authors in order for abstract to be considered.

GUIDELINES FOR SUBMISSION

  • Abstracts must be proofread carefully. Author will be responsible for correct grammar and spelling.
  • Abstract content should not exceed 2,500 characters. Spaces are included.
  • Abstract title should be no more than 150 characters, excluding spaces.
  • Abstracts submitted should not have been published or presented elsewhere prior to the CMSC meeting.
  • In support of improving patient care, the Consortium of Multiple Sclerosis Centers (CMSC) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. CMSC is committed to comply with the rules and guidelines set forth by these agencies to ensure that these standards are strictly followed. The work of commercial interest authors and presenters will be considered for review provided that the content focuses on basic science and not on the product or on the commercial aspects of the discovery. Acceptance of an abstract for Whitaker Track depends solely on the decision of the CMSC Whitaker Review Committee.
  • Slides containing scientific or clinical information may not be presented if they have been developed by a commercial interest.
  • Abstracts must follow formatting guidelines. Please make sure that all information is correct. Abstracts submitted with incomplete information will not be reviewed.

ACCEPTED ABSTRACTS

Review Process: The Whitaker Review Committee will review submissions. Submissions are evaluated for clarity, nature and originality and scientific merit. Submissions will be evaluated on an equal basis, whether theme related or of general interest, although preference will be given to data-based submissions for presentations.
Notification: Authors will be notified of acceptance or rejection of abstracts no later than February 29, 2021. All communication will be made through the contact person.